Overview
NICE has developed a medtech innovation briefing (MIB) on iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia.
NICE has also published interventional procedures guidance on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia.